Ultivent Cozycap - Image 1
Express delivery icon 12-24 HOURS

ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন

Register
6564 people viewed this
info-icon
info-icon
Chronic Disease Lab Promotion

Ultivent Cozycap

Inhalation Capsule-(50mcg+110mcg)
brand logo
Square Pharmaceuticals PLC.
6 x Inhalation Capsules (1 Strip)
৳ 327.24
৳ 360
9% OFF

Medicine Overview of Ultivent Cozycap 50mcg+110mcg Inhalation Capsule

Switch language Iconবাংলা

Introduction

Ultivent Cozycap is used for the treatment of chronic obstructive pulmonary disorder (a lung disorder in which the flow of air to the lungs is blocked). It helps in relaxing the muscles of the air passages and making it easier to breathe. It relieves coughing, wheezing and feeling short of breath. Your doctor will tell you how often you need to use your inhaler. The effect of this medicine may be noticeable after a few days but will only reach its maximum after a few weeks. This medicine must be used regularly to be effective, so go on taking it even if you don't have any symptoms. That means it's doing its job. If you stop taking it your COPD may get worse. This medicine should not be used to relieve sudden shortness of breath. To get the benefit from this medicine you need to make sure you get your inhaler technique right, otherwise, it Does not work as well. The most common side effects are indigestion, high blood pressure, nasopharyngitis (inflammation of the throat and nasal passages), chest pain, fever, sore throat, cough, headache, dizziness, inflammation of the nose, and sinus inflammation. If you get there, don't stop taking it but do talk to your doctor. You can prevent some of these symptoms by rinsing your mouth and throat with water or brushing your teeth after using your inhaler. There are other, rarer side effects which can be serious. Talk to your doctor if you're worried about them.

Uses of Ultivent Cozycap

  • Chronic obstructive pulmonary disease (COPD)

Side effects of Ultivent Cozycap

Common
  • Indigestion
  • High blood pressure
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Chest pain
  • Fever
  • Urinary retention
  • Sore throat
  • Cough
  • Headache
  • Dizziness
  • Allergic reaction
  • Increased glucose level in blood
  • Inflammation of the nose
  • Sinus inflammation
  • Urinary tract infection

How to use Ultivent Cozycap

Take this medicine in the dose and duration as advised by your doctor. Check the label before use.

How Ultivent Cozycap works

Ultivent Cozycap is a combination of two medicines: Indacaterol and Glycopyrrolate which treat chronic obstructive pulmonary disease (COPD). Indacaterol is a bronchodilator which works by relaxing the muscles in the airways and widens the airways. Glycopyrrolate is an anticholinergic which works by decreasing the secretions in the airways. Together, they make breathing easier.

Quick Tips

  • Ultivent Cozycap is a combination of two medicines that makes breathing easier for patients with chronic obstructive pulmonary disease (COPD).
  • This medicine is for inhalation only. The tablet should not be swallowed.
  • It should be taken at the same time each day.
  • It does not work right away and should not be used to relieve sudden breathing problems.
  • Take the first dose of this medicine under medical supervision as it may cause wheezing or tightening of the airways (bronchospasm) immediately after using.
  • Dry mouth may occur as a side effect. Frequent mouth rinses, good oral hygiene, increased water intake and sugarless candy may help.
  • Your doctor may regularly monitor your blood potassium levels as low oxygen levels in the blood (hypoxia) and COPD medicines such as Ultivent Cozycap can lower potassium levels in blood.

Brief Description

Indication

Bronchodilator treatment to relieve symptoms in patients with, chronic obstructive pulmonary disease (COPD).

Administration

For inhalation use only. The capsules must not be swallowed.

Adult Dose

Adult Chronic Obstructive Pulmonary Disease (COPD) Inhale 1 cap with inhaler once daily. Hepatic Impairment: This can be used at the recommended dose in patients with mild and moderate hepatic impairment. There are no data available for the use of Indacaterol + Glycopyrronium Breezhaler in patients with severe hepatic impairment, therefore caution should be observed in these patients.

Child Dose

Safety and efficacy not established

Renal Dose

Renal Impairment: This can be used at the recommended dose in patients with mild to moderate renal impairment. In patients with severe renal impairment or end-stage renal disease requiring dialysis it should be used only if the expected benefit outweighs the potential risk.

Contraindication

Hypersensitivity to indacaterol, glycopyrronium or to any of the excipients of Indacaterol + Glycopyrronium. All LABAs are contraindicated in patients with asthma without use of a long-term asthma control medication Indacaterol/glycopyrrolate is not indicated for the treatment of asthma Use in children: This should not be used in patients <18 years.

Mode of Action

Glycopyrronium: Long-acting muscarinic antagonist (LAMA); often referred to as an anticholinergic; produces bronchodilation by inhibiting acetylcholine’s effect on muscarinic receptors in the airway smooth muscle Indacaterol: Long-acting beta2-agonist (LABA); stimulates intracellular adenyl cyclase, causing conversion of ATP to cyclic AMP; increased cyclic AMP levels cause relaxation of bronchial smooth muscle

Precaution

Concomitant use w/ long-acting beta-agonists or long-acting muscarinic antagonists. Not for the treatment of asthma. Immediately discontinue use if hypersensitivity & paradoxical bronchospasm occurs. Narrow-angle glaucoma, urinary retention, CV disorders (CAD, acute MI, cardiac arrhythmia, HTN), convulsive disorders or thyrotoxicosis, severe renal impairment; hypokalaemia; hyperglycaemia. Pregnancy & lactation.

Side Effect

1-10% Nasopharyngitis (4.1%),Hypertension (2%),Back pain (1.8%),Oropharyngeal pain (1.6%)

Interaction

Decreases levodopa effects. Effects may be enhanced by using drugs with antimuscarinic properties or MAOIs concurrently. May antagonise the GI effects of cisapride, metoclopramide and dompeidone. Potentially Fatal: IV admin in the presence of cyclopropane anesth can result in ventricular arrhythmias.

Buy Ultivent Cozycap from Arogga

In Bangladesh, you can get the original Ultivent Cozycap. Select your favorite one from a large collection of medicine products. Order from App to get more offers and better experience.

What is the price of Ultivent Cozycap in Bangladesh?

The latest price of Ultivent Cozycap in Bangladesh is 327.24. You can buy Ultivent Cozycap at the best price from Arogga. Order online through our website or mobile app and get fast home delivery anywhere in Bangladesh. Cash on Delivery (COD) is available all over Bangladesh.

Frequently Questions & Answers

Is the product authentic?

Yes. Arogga sources all medicines and health products directly from trusted suppliers, distributors, or manufacturers. Every product is verified before delivery.

Does Arogga deliver all over Bangladesh?

Yes, Arogga delivers nationwide. You can order from anywhere in Bangladesh.

Is Cash on Delivery(COD) available?

Yes, Cash on Delivery is available across Bangladesh for most products.

How long does delivery take?

Delivery usually takes 24–48 hours inside Dhaka and 3–5 days outside Dhaka, depending on location and courier load.

Can I return or replace the product?

If the product is damaged, incorrect, or expired, you can request a replacement or refund according to Arogga’s return policy.

Safety Advices

Rocket Icon
UNSAFE
It is unsafe to consume alcohol with Ultivent Cozycap.
Rocket Icon
CONSULT YOUR DOCTOR
Ultivent Cozycap may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Rocket Icon
SAFE IF PRESCRIBED
Ultivent Cozycap is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Long-term use of Ultivent Cozycap might reduce milk production.
Rocket Icon
No interaction found/established
Rocket Icon
No interaction found/established
Rocket Icon
No interaction found/established
Disclaimer

The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not be treated as a replacement for physical medical consultation or advice. We do not guarantee the accuracy and the completeness of the information so provided. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company. We do not take any responsibility for the consequences arising out of the aforementioned information and strongly recommend you for a physical consultation in case of any queries or doubts.